RANKL as the master regulator of osteoclast differentiation

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224

Regulation of type I interferon responses

Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.

Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351

Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.

Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778

Genetic regulation of osteoclast development and function

Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,720

RANK is essential for osteoclast and lymph node development.

Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478

Autophagy in Rheumatoid Arthritis: Molecular Mechanisms, Diagnostic Biomarkers, and Emerging Therapeutic Strategies

Nasrollahizadeh, A., Rahmati, S., Chahkand, M. S. G., Moallem, F. E., Azarm, E., Dadkhah, P. A., Karimi, M., Amini‐Salehi, E., & Karimi, M. A. (2026) · Inflammation · doi:10.1007/s10753-025-02406-1 · Cited by 3

Advanced bone-targeted nanomaterials for the systemic treatment of osteoporosis

Fan, W., Wu, P., Liu, C., & Chen, X. (2026) · Regenerative Biomaterials · doi:10.1093/rb/rbag065 · Cited by 3

The mechanism of action and therapeutic potential of macrophages in osteoporosis: from polarization balance to targeted regulation

Liu, C., Wang, T., Ren, Z. S., Luo, J., Wang, Z., Liang, Y., & Peng, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1738143 · Cited by 3

New flavan trimer from Daemonorops draco as osteoclastogenesis inhibitor

Tsuchiya, A., Suzuki, M., Ito, R., Batubara, I., Yamauchi, K., & Mitsunaga, T. (2023) · Fitoterapia · doi:10.1016/j.fitote.2023.105757 · Cited by 3

Microbial chaperonin 60 inhibits osteoclast differentiation by interfering with RANK/RANKL binding and overexpression of lipocalin2

Cho, J.-Y., Woo, H.-E., Yeom, J., An, M., Ma, S., Yim, D. J., Kim, S., & Lim, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119850 · Cited by 3

TNFRSF11B-modified umbilical cord mesenchymal stem cells as a novel strategy for bone-related diseases by suppressing osteoclast activity

Ding, M., Ding, Q., Liu, Z., Wang, L., Pei, K., Hu, J., Yan, L., & Zhang, J. V. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-05850-9 · Cited by 3

Suppression of NFATc1 through NF-kB/PI3K signaling pathway by Oleandrin to inhibit osteoclastogenesis and bone resorption

Li, Z., Chen, K., Yu, Q., Li, Y., Tong, S., Xu, R., Hu, R., Zhang, Y., & Xu, W. F. (2024) · Engineered Regeneration · doi:10.1016/j.engreg.2024.01.005 · Cited by 3

Bone Metastasis Mediates Poor Prognosis in Early‐Onset Gastric Cancer: Insights Into Immune Suppression, Coagulopathy, and Inflammation

Yin, S., Zhai, X., Li, Y., Zeng, R., Zhang, D., Sun, X., Zhang, Z., Wang, H., & Wang, C. (2025) · Cancer Medicine · doi:10.1002/cam4.70737 · Cited by 5

Effects of areca nut consumption on cell differentiation of osteoblasts, myoblasts, and fibroblasts

Chang, Y.-F. (2022) · Biocell · doi:10.32604/biocell.2023.025743 · Cited by 3

Mechanisms of isorhamnetin inhibition of osteoclast differentiation: insights from molecular dynamics simulations and in vitro/in vivo experiments

Zhou, Y., Li, S., Hong, B., Wang, Z., Shao, Y., Wu, M., & Wang, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1551257 · Cited by 3

Human platelet-derived extracellular vesicle fractions modulate bone cell metabolism and biologize volume-stable β-TCP matrix in vitro

Döding, A., Güllich, A., Koch, S., de Miroschedji, K., & Schulze‐Späte, U. (2025) · BMC Medicine · doi:10.1186/s12916-025-04371-w · Cited by 2

Osteocyte transition induced by quiescent vascular smooth muscle cells through paracrine signaling is independent of shear stress

Fernandes, C. J. C., van der Eerden, B. C. J., da Silva, R. A., Fuhler, G. M., Peppelenbosch, M. P., & Zambuzzi, W. F. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.120092 · Cited by 2

ISO-1 sustained-release hydrogel repairs infected bone defects by suppressing osteoblast pyroptosis and enhancing osteogenic differentiation via the MIF-CD74/PI3K/AKT signaling pathway

Shi, X., Wei, M., Yin, Z., Li, M., Wang, J., Fu, P., Yuan, L., Li, Y., Wu, Y., & Xu, Y. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103187 · Cited by 2

Neurovascular coupling in bone regeneration: Mechanisms, advanced biomaterials and challenges

Ma, Y., Jiang, N., Chen, L., Zhang, H., Cai, X. L., Gulati, K., He, D., Cai, Z., & Liu, Y. (2026) · BMEMat · doi:10.1002/bmm2.70090 · Cited by 2

From force to resorption: mechanotransduction, osteoclasts, prevention

Shen, F., Xia, X., Han, Y., Yu, M., & Ding, W. (2026) · Progress in Orthodontics · doi:10.1186/s40510-026-00625-2 · Cited by 3

Expression and functional characterization of bovine receptor activator of NF-κB ligand (RANKL)

Chapuis, A. F., Alfituri, O. A., Hope, J. C., Stevens, J., Moore, S. J., McLean, K., Androscuk, D., & Dry, I. R. (2023) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2023.110705 · Cited by 2

Unveiling the intricacies of bone homeostasis: Epigenetic regulation, extracellular vesicles, and angiogenesis integration

Fernandes, C. J. D. C. (2024) · Extracellular Vesicle · doi:10.1016/j.vesic.2024.100042 · Cited by 2

PTHrP participates in the bone destruction of middle ear cholesteatoma via promoting macrophage differentiation into osteoclasts induced by RANKL.

Xie, S., Jin, L., Fu, J., Yuan, Q., Yin, T., Ren, J., & Liu, W. (2024) · PubMed Central · doi:10.11817/j.issn.1672-7347.2024.230482 · Cited by 2

Assessment of Osteoprotegerin and Receptor Activator of Nf-Kb Ligand in Malaysian Male Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

Bitar, A. N., Al‐Mansoub, M. A., Syed-Sulaiman, S. A., Saqallah, F. G., Ali, I. A. H., Alshehade, S. A., & Hayat-Khan, A. (2024) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.24000192 · Cited by 2

Buqi-Tongluo Decoction inhibits osteoclastogenesis and alleviates bone loss in ovariectomized rats by attenuating NFATc1, MAPK, NF-κB signaling

Li, Y., Yuan, J., Deng, W., Li, H., Lin, Y., Yang, J., Chen, K., Qiu, H., Wang, Z., Kuek, V., et al. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60810-7 · Cited by 2

The DHH-DHHA1 domain phosphodiesterase of Mycoplasma bovis employs multiple strategies to modulate macrophage cellular processes

Zhu, X., Chen, Y., Lu, D., Zhao, G., Liu, Y., Wang, A., & Guo, A. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141585 · Cited by 2

Discovery of Polyketides and Alkaloids From the Mangrove Endophytic Fungus Diaporthe sp. and Their Anti‐Osteoclastogenic Bioactivities

Lu, H., Feng, Y., Lin, M., Yu, X., Liu, Y., Tan, Y., & Luo, X. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500858 · Cited by 2

Investigation of Giant Cell Tumor of Bone and Tissue Engineering Approaches for the Treatment of Giant Cell Tumor of Bone

Anandan, D., Kumar, A., Jeyakkani, M. N., Inja, D. B., & Jaiswal, A. K. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00441 · Cited by 1

Elevated sclerostin levels contribute to reduced bone mineral density in non-ambulatory stroke patients

Lee, H. K., Notario, G. R., Won, S. Y., Kim, J. H., Lee, S. M., Kim, H. S., & Cho, S. (2025) · Bone Reports · doi:10.1016/j.bonr.2025.101829 · Cited by 1

Tryptanthrin, a constituent of Persicaria tinctoria , suppresses osteoclastogenesis and enhances the expression of tight junction proteins and cell adhesion molecules in gingival epithelial cells

Hatada, Y., Inagaki, Y., Nakamura, D., Akizuki, M., Iwata, Y., Kido, R., Bando, M., & Yumoto, H. (2026) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbag025 · Cited by 1

Non-covalent proteasome inhibitor PI1840 suppresses osteoclastogenesis and prevents LPS-induced osteolysis in mice

Xia, Y., Fuli, Z. H. A. O., Dang, C., Bai, J., Li, Y., Yang, J., You, Q., Tang, Q., Dou, W., & Liu, M. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02175-9 · Cited by 1

Molecular-level understanding of the aging bone and regeneration mechanisms using computational methods

Stojceski, F., Zaverdas, H., Danani, A., Mengoni, A., Ledda, M., Labate, G. F. D., Kalogeras, A. P., Theofilatos, K., Mavroudi, S. P., & Grasso, G. (2026) · Osteoporosis International · doi:10.1007/s00198-026-07903-z · Cited by 1

Benzo[a]pyrene exacerbates bone destruction by inhibiting Treg differentiation, impairing Treg function and promoting osteoclastogenesis in rats with collagen-induced arthritis

Deng, T., Wang, X., Shi, T. S., Jiao, Y., Geng, Q., Wang, Z., & Xiao, C. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120135 · Cited by 1

8-Epixanthatin Suppresses RANKL-Induced Osteoclast Differentiation via Inhibition of NF-κB and MAPK Signaling

Zhang, L., & Deepak, V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083578 · Cited by 1

Research Progress of Ferrosoferric Oxide Nanoparticles in Bone Regeneration and Disease Treatment

Song, J., Li, J., Ding, Y.-B., Shun-zhi, 杨. Y., Sun, L., Yang, Y., Lin, Z., Feng, Y.-C., & Liu, F. X. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s570169 · Cited by 1

Bone involvement in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis

Rotta, D., Fassio, A., Adami, G., & Rossini, M. (2026) · Technical report · doi:10.1016/b978-0-443-23722-5.00012-1 · Cited by 1

RANKL blockade for cancer cachexia; a new therapeutic opportunity?

Tsourdi, E. A. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4511 · Cited by 1

Calcitonin Gene-related Peptide Inhibits Osteoclast Differentiation by Inducing the Negative Regulators MafB and Bcl6

Ishizuka, K. (2022) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.31.87 · Cited by 1

Combination ofin silicoand cell culture strategies to predict biomaterial performance: Effects of sintering temperature on the biological properties of hydroxyapatite

de Almeida, G. S., Ferreira, M. R., Fernandes, C. J. D. C., de Biagi, C. A. O., Silva, W. A., Rangel, E. C., Lisboa‐Filho, P. N., & Zambuzzi, W. F. (2024) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35389 · Cited by 1

Galla Turcica alleviates gingiva inflammation and alveolar bone resorption via regulating Th1/Th17 in a mouse model of periodontitis

Han, Y., Yu, C., & Yu, Y. (2024) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-024-00745-2 · Cited by 1

LncRNA in periodontal tissue‐derived cells on osteogenic differentiation in the periodontitis field

Du, Y., Guan, X., Zhu, Y., Jin, S., & Liu, J. (2024) · Oral Diseases · doi:10.1111/odi.14970 · Cited by 1

In planta production of human-derived RANKL

Lee, J.-H., Geem, K. R., Chen, Z., Jeong, J., Park, S.-W., & Lee, D. W. (2024) · Plant Biotechnology Reports · doi:10.1007/s11816-024-00917-1 · Cited by 1

Adiponectin receptors agonist alters microbiota to improve implant osseointegration in diabetic mice

Wang, X., Lin, L., & Yao, Q. (2024) · Oral Diseases · doi:10.1111/odi.15118 · Cited by 1

Pdk3’s role in RANKL-induced osteoclast differentiation: insights from a bone marrow macrophage model

Zhang, N., Wang, L., & Ye, X. (2024) · PeerJ · doi:10.7717/peerj.18222 · Cited by 1

Effects of aged garlic extract on experimental periodontitis in mice

Kuang, C., Hirai, A., Kamei‐Νagata, C., Nango, H., Ohtani, M., Omori, K., & Takashiba, S. (2025) · Biomedical Reports · doi:10.3892/br.2025.1975 · Cited by 1

PRKG1 mutation identified by whole-exome sequencing: a potential genetic etiology for He-Zhao deficiency

Hu, X., Wang, D., Yang, X., Song, Z., Wang, Z., Zhang, J., Wan, C., & He, L. (2022) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000128 · Cited by 1

Bone Tumours - A Comprehensive Review of Selected Topics

Amarasekera, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100923

Perspective Chapter: Breast-Tumor-Derived Bone Pre-Metastatic Disease – Interplay between Immune and Bone Cells within Bone Marrow Microenvironment

Monteiro, A. C., & Bonomo, A. C. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.107278 · Cited by 1

Polymethoxyflavones and Bone Metabolism

Hirata, M., Tominari, T., Matsumoto, C., Kasuga, U., Ikeda, K., Miyaura, C., Grundler, F. M. W., & Inada, M. (2025) · Nutrients · doi:10.3390/nu17050822 · Cited by 1

Effects of Autoantibodies on Osteoclasts

Sokolova, M. V., & Steffen, U. (2021) · Osteologie/Osteology · doi:10.1055/a-1592-1305

Salt inducible kinases and PTH1R action

Yoon, S.-H., Tang, C.-C., & Wein, M. N. (2022) · Vitamins and hormones · doi:10.1016/bs.vh.2022.04.008 · Cited by 1

Rare coding variants in NOX4 link high superoxide levels to psoriatic arthritis mutilansPreprint

Wang, S., Nikamo, P., Laasonen, L., Guðbjörnsson, B., Ejstrup, L., Iversen, L., Lindqvist, U. R. C., Alm, J. J., Eisfeldt, J., Zheng, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.06.543425

Deficiency of protein phosphatase 5 resists osteoporosis in diabetic mice

Wang, J., Zhao, C., Zhao, W., & Li, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34027

CONHECIMENTO DE ACADÊMICOS DE ODONTOLOGIA NO DIAGNÓSTICO DIFERENCIAL DA FLUOROSE E HIPOPLASIA DE ESMALTE

Palma, A. B. O., Tonelli, B. Q., de Oliveira, A. L., Silva, A. M., Rodrigues, C. E. D. F., BATISTA, C. M. L., Luiz, J. M. V. A., Martins, J. V. S., & Ribeiro, M. C. M. (2024) · doi:10.22533/at.ed.9602422072

Membrane-free stem cell components suppress osteoclast differentiation: Implications for oral regenerative treatment

Ahn, S.-W., Kim, E.-J., Kim, M. K., Shin, S. H., & Kwon, J. (2024) · Journal of Dental Sciences · doi:10.1016/j.jds.2024.08.005

Bmi-1 plays an important role in preventing bone aging by regulating the bone microenvironment

Li, L. (2024) · International Journal of Clinical and Experimental Pathology · doi:10.62347/diij2884

Maternal Exposure to Polystyrene Nanoplastics During Gestation and Lactation Impaired Skeletal Growth in Progeny Mice by Inhibiting Neutrophil Extracellular Trap FormationPreprint

Chen, G., Li, J., Wang, S., Cao, L., van Gestel, C. A. M., Qiu, H., Li, X., Sun, Q., Zhao, H., & Xiong, S. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5105191

FK866 attenuates receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis

Ok, C. Y., Jang, H.-O., Bae, M., & Bae, S. (2025) · International Journal of Oral Biology · doi:10.11620/ijob.2025.50.1.17

Exploring the Diverse Biological and Pharmacological Properties of Cyclolinopeptides From Flax: A Comprehensive Study

Xiao, Y., Wang, R., Long, Y., Dai, W., & Nie, H. (2025) · ChemistrySelect · doi:10.1002/slct.202501324

The Role of miR ‐200b‐3p in Targeting PTHrP in the Pathogenesis of Bone Destruction in Cholesteatoma

Liu, W., Jin, L., Yuan, Q., He, J., Fu, J., Du, Y. X., & Xie, S. (2025) · The Laryngoscope · doi:10.1002/lary.32317

Anabolic effects of Sost deficiency partially offset Opg deficiency–induced catabolism in cortical bone

Koide, M., Yamashita, T., Kobayashi, Y., Yasuda, H., Nakamura, M., & Udagawa, N. (2025) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-025-01653-4

Schisandrol B inhibits osteoclastogenesis and mitigates estrogen deficiency-induced bone loss by targeting TRAF6-NOX1 pathway

Su, Y., Liang, J., Lian, H., Chen, L., Xu, J., Zhao, J., & Liu, Q. S. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157669

Additional file 3 of Review of potential medical treatments for middle ear cholesteatoma

Schürmann, M., Goon, P. K. C., & Sudhoff, H. (2022) · Figshare · doi:10.6084/m9.figshare.21162819

Additional file 2 of Review of potential medical treatments for middle ear cholesteatoma

Schürmann, M., Goon, P. K. C., & Sudhoff, H. H. (2022) · Figshare · doi:10.6084/m9.figshare.21162813

Nuclear factor I/A: A novel multifunctional player in bone homeostasis via coordinating osteoclast and osteoblast differentiation

Dong, Y., Sun, H., Zhou, J., Li, F., Yang, W., Xie, Y., Li, X., & Wang, B. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102109

Microalgal extract from Pseudocalidococcus azoricus KCTC AG61299 as a potential inhibitor of osteoclast formation for osteoporosis therapy

Lian, X.-D., Lee, J., Kang, S., Lee, J., Guan, Y., Lee, M.-K., Jung, K., & Li, Z. (2026) · Algal Research · doi:10.1016/j.algal.2026.104663

Etude de la transmission intercellulaire du VIH-1 vers les macrophages par fusion cellule-cellule

Mascarau, R. (2022) · theses.fr (ABES) · doi:10.70675/2e3aacaazcd4fz49a5zb350zcd4933447d78

Significant association of RANKL polymorphisms with bone metastasis among patients with breast cancer

Lian, H., Zhou, S., He, H., Liu, Q., & Zhao, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1788455

Osteoimmunology: Can We Prevent Bone Loss in Rheumatoid Arthritis with Modern Antirheumatic Drugs?

Raterman, H. G., Adami, G., Clark, P., Haugeberg, G., Torres, J. M., Neira, L. V., Zakraoui, L., Zerbini, C. A. F., Messina, O. D., Lems, W. F., et al. (2026) · Calcified Tissue International · doi:10.1007/s00223-026-01504-y

cGAS-STING pathway mediation in osteoclast function and bone fracture healing

Zheng, M., Zhao, L., Nian, S., Wei, Q., Zhou, P., & Tang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1789655 · Cited by 1

The role of osteoprotegerin in colorectal cancer: Molecular interactions, mechanistic insights, and therapeutic implications

Ng, C. Y. J., Lyu, Z., Meng, L., Xu, L., Wang, N., & Zhong, L. L. D. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.06.002

Immunomodulatory effect of electrodeposited calcium phosphate coatings on early inflammatory response to bone implant

Thoraval, L., Drevet, R., Guillaume, C., Bour, C., Benhayoune, H., & Velard, F. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215043

Immunomodulatory role of MINDIN in bone microenvironment under inflammatory conditions

Rodríguez, V. A., Álvarez‐Carrión, L., Romeo, M., Gutiérrez-Rojas, I., de Casasola-Rodríguez, G. G., & Rodríguez, J. A. A. (2026) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.20960/revosteoporosmetabminer.00102

Microbial and host‐derived biomarkers for the diagnosis and management of peri‐implant diseases

Quach, S. S., Ramanauskaitė, A., Ivanovski, S., Han, P., Schwarz, F., & Cafferata, E. A. (2026) · Periodontology 2000 · doi:10.1111/prd.70083

Oxidative Stress and Metabolic Reprogramming in Osteoclastogenesis: Molecular Mechanisms and Antioxidant Therapy for Bone Disorders

Alam, M. I., Farhana, F., Khan, T. R., Sharmin, F., Hurunnaher, M., Katsuma, Y., Sakai, E., & Sumita, Y. (2026) · Antioxidants · doi:10.3390/antiox15101305

O‐ GlcNAcylation : A Metabolic‐Immune Hub Regulating Macrophage Fate and Osteoclast Differentiation

Zhang, J., 田坤, Zhuang, N., Zhang, X., & Zhang, Y. (2026) · Oral Diseases · doi:10.1111/odi.70498

Traditional Chinese medicine regulating Wnt/β-catenin and OPG/RANKL/RANK pathways in osteoporosis: a narrative review based on bone coupling and pathological subtype differences

Song, S. P., Li, J.-M., Feng, S., & Lu, H.-M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1924175

CAMKK1 couples STIM1-dependent Ca2+ signaling to mitochondrial metabolic adaptation during osteoclastogenesis

Ren, Q., Ma, Y., Huang, Y., Liu, Y., Zhang, X., Jia, S., Yan, L., & Wang, S. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109671

Polyol pathway inhibition by epalrestat attenuates pathological bone loss through redox homeostasis and sorbitol-linked calcium signaling

Yao, C., Cai, Z., Song, H., Xue, Q., Cai, B., He, W., Kong, X., Yang, T., Jin, J., Li, J., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109698

BindingDB Entry 50020568: Discovery of a First-in-Class GPR183 Antagonist for the Potential Treatment of Rheumatoid Arthritis.

BindingDB (2024) · UC San Diego · doi:10.7270/q2w09bdm

What Makes an Osteoclast Special?

Karsenty, G. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.05.005 · Cited by 1

Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701

9 Cytokine and Growth Factor Regulation of OsteoclastogenesisPreprint

Takayanagi, H. (2009) · Cold Spring Harbor Monograph Archive · doi:10.1101/087969825.53.263

Novel osteoclast signaling mechanisms

Shinohara, M., & Takayanagi, H. (2007) · Current Osteoporosis Reports · doi:10.1007/s11914-007-0005-1 · Cited by 72

Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation

Park, J. H., Lee, N. K., & Lee, S. Y. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.0225 · Cited by 688